Lucas MG, Stephenson TP, Nargund V (February 2005). "Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia". BJU International. 95 (3): 354–357. doi:10.1111/j.1464-410X.2005.05299.x. PMID15679793. S2CID30254915.
Roehrborn CG, Siami P, Barkin J, Damião R, Major-Walker K, Morrill B, et al. (February 2008). "The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study". The Journal of Urology. 179 (2): 616–621, discussion 621. doi:10.1016/j.juro.2007.09.084. PMID18082216.
Lucas MG, Stephenson TP, Nargund V (February 2005). "Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia". BJU International. 95 (3): 354–357. doi:10.1111/j.1464-410X.2005.05299.x. PMID15679793. S2CID30254915.
Roehrborn CG, Siami P, Barkin J, Damião R, Major-Walker K, Morrill B, et al. (February 2008). "The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study". The Journal of Urology. 179 (2): 616–621, discussion 621. doi:10.1016/j.juro.2007.09.084. PMID18082216.
Lucas MG, Stephenson TP, Nargund V (February 2005). "Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia". BJU International. 95 (3): 354–357. doi:10.1111/j.1464-410X.2005.05299.x. PMID15679793. S2CID30254915.